<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN" "http://jats.nlm.nih.gov/publishing/1.0/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article-commentary" dtd-version="1.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="issn">1043-3155</journal-id>
<journal-id journal-id-type="nlm-ta">Pediatr Neurol Briefs</journal-id>
<journal-id journal-id-type="pmc">pedneurbriefs</journal-id>
<journal-id journal-id-type="iso-abbrev">Pediatr Neurol Briefs</journal-id>
<journal-title-group>
<journal-title>Pediatric Neurology Briefs</journal-title>
<abbrev-journal-title>Pediatr Neurol Briefs</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1043-3155</issn>
<issn pub-type="epub">2166-6482</issn>
<issn-l>1043-3155</issn-l>
<publisher>
<publisher-name>Pediatric Neurology Briefs Publishers</publisher-name>
<publisher-loc>Chicago, IL, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PNB-29-94</article-id>
<article-id pub-id-type="doi">10.15844/pedneurbriefs-29-12-5</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Complementary/Integrative Therapies</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v2">
<subject>Neurology</subject>
<subject>Pediatrics</subject>
<subject>Nervous System Diseases</subject>
<subject>Child Development</subject>
<subject>Brain Diseases</subject>
<subject>Neurosurgery</subject>
<subject>Child</subject>
<subject>Infant</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Complementary/Alternative versus Prescription Medications</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0173-7931</contrib-id>
<name>
<surname>Millichap</surname>
<given-names>J. Gordon</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="AF0001">1</xref>
<xref ref-type="aff" rid="AF0002">2</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
</contrib-group>
<aff id="AF0001">
<label>1</label>Division of Neurology, Ann &#x0026; Robert H. Lurie Children&#x0027;s Hospital of Chicago, Chicago, IL</aff>
<aff id="AF0002">
<label>2</label>Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL</aff>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Correspondence: Dr. J. Gordon Millichap, E-mail: <email xlink:href="jgmillichap@northwestern.edu">jgmillichap@northwestern.edu</email>
</corresp>
</author-notes>
<pub-date date-type="pub" publication-format="print">
<month>12</month>
<year>2015</year>
</pub-date>
<pub-date date-type="pub" publication-format="electronic">
<day>19</day>
<month>01</month>
<year>2016</year>
</pub-date>
<volume>29</volume>
<issue>12</issue>
<fpage>94</fpage>
<lpage>94</lpage>
<history>
<date date-type="received">
<day>12</day>
<month>01</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>01</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright: &#x00A9; 2015 The Author(s)</copyright-statement>
<copyright-year>2015</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This work is licensed under the <uri xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</uri>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<related-article id="R1" related-article-type="commentary-article" ext-link-type="doi" xlink:href="10.1016/j.pediatrneurol.2015.11.003">
<article-title>Patient use of complementary and alternative medicines in an outpatient pediatric neurology clinic</article-title>
</related-article>
<abstract abstract-type="web-summary" specific-use="electronic-only">
<p>Investigators from the Mayo Clinic, Rochester MN, determined the use of complementary and alternative medicine (CAM) in an outpatient pediatric neurology clinic, and assessed family attitudes toward the efficacy of CAM versus prescription medications.</p>
</abstract>
<kwd-group>
<kwd>Complementary and Alternative Medicine</kwd>
<kwd>Headache</kwd>
<kwd>Chronic Fatigue</kwd>
<kwd>Epilepsy</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<p>Investigators from the Mayo Clinic, Rochester MN, determined the use of complementary and alternative medicine (CAM) in an outpatient pediatric neurology clinic, and assessed family attitudes toward the efficacy of CAM versus prescription medications. Questionnaires distributed to 500 consecutive patients alluded to the child&#x0027;s diagnosis, use of CAM, efficacy of CAM and the prescription medication. Of 484 surveys returned, 327 were usable. Only 17.4% admitted initially to the use of CAM to treat neurological problems. At follow-up, 41.6% of patients understood that they used CAM. Disorders treated with a significant increased prevalence of CAM included headache (50.8% with headache used CAM vs 35.7% without headache, p=0.008), chronic fatigue (63.2% vs 38.8%, p=0.005), and sleep disorders (77.1% vs 37.3%, p&#x003C;0001). Epilepsy was among disorders least likely to be treated with CAM (107/327, 32.7%), Melatonin was the most widely used CAM, followed by probiotics. Gluten-free diet was among the top 10 popular modalities. Only 38.5% of CAM using patients recognize that they are taking CAM, a finding that demonstrates the need to inquire in depth about use of CAM. Patients less satisfied with their prescription medications are more likely to use CAM, reflecting the less tractable nature of their disorders. Few families (4.9%) managed to treat solely with CAM. [<xref ref-type="bibr" rid="CIT0001">1</xref>]</p>
<p>COMMENTARY. The Mayo Clinic, renown for its allopathic medicine, must be congratulated on a detailed study of the prevalence of use and perceived efficacy of complementary and alternative medicine (CAM). The list of 56 commonly used CAM modalities showing their frequency of use is particularly of interest and emphasizes the popularity of melatonin, probiotics, music therapy, and omega 3 among parents of patients in this particular clinic. While different communities may demonstrate different patterns of use of CAM, the educational level did not affect the use of CAM in this community. Most pediatric CAM use is not discussed with patients, despite the interest frequently shown by parents [<xref ref-type="bibr" rid="CIT0002">2</xref>]. The authors note that patients are less likely to report the use of CAM unless asked about specific modalities. Making the Mayo Clinic list of commonly used CAM modalities available to patients should facilitate the physician-parent discussion and lead to a better understanding of the indications and need for evaluation of this form of therapy. For headache, the most frequently treated disorder using CAM, long-term prophylactic drug therapy is appropriate only after exclusion of headache precipitating trigger factors, including dietary factors [<xref ref-type="bibr" rid="CIT0003">3</xref>].</p>
</body>
<back>
<sec>
<title>Disclosures</title>
<p>The author has declared that no competing interests exist.</p>
</sec>
<ref-list>
<ref id="CIT0001">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kenney</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Jenkins</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Youssef</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kotagal</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Patient use of complementary and alternative medicines in an outpatient pediatric neurology clinic</article-title>
<source>Pediatr Neurol</source>
<year>2015</year>
<month>Jan</month>
<day>11</day>
<comment>Epub ahead of print</comment>
<pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2015.11.003</pub-id>
</element-citation>
</ref>
<ref id="CIT0002">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doering</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Reuner</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kadish</surname>
<given-names>NE</given-names>
</name>
<name>
<surname>Pietz</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Schubert-Bast</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Pattern and predictors of complementary and alternative medicine (CAM) use among pediatric patients with epilepsy</article-title>
<source>Epilepsy Behav</source>
<year>2013</year>
<month>Oct</month>
<volume>29</volume>
<issue>1</issue>
<fpage>41</fpage>
<lpage>46</lpage>
<pub-id pub-id-type="doi">10.1016/j.yebeh.2013.06.025</pub-id>
<pub-id pub-id-type="pmid">23933629</pub-id>
</element-citation>
</ref>
<ref id="CIT0003">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Millichap</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Yee</surname>
<given-names>MM</given-names>
</name>
</person-group>
<article-title>The diet factor in pediatric and adolescent migraine</article-title>
<source>Pediatr Neurol</source>
<year>2003</year>
<month>Jan</month>
<volume>28</volume>
<issue>1</issue>
<fpage>9</fpage>
<lpage>15</lpage>
<pub-id pub-id-type="doi">10.1016/S0887-8994(02)00466-6</pub-id>
<pub-id pub-id-type="pmid">12657413</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
